Training new scientists to improve HIV treatment and care
Official title: Mentoring Scientists for Careers in HIV Translational Clinical Research
Funded at University of California, San Francisco · NIH-10897028 · Data updated 2026-11-12
This study is all about helping young scientists learn more about HIV and how it stays in the body, so they can come up with new ideas for better treatments that could help patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $191,388 |
| NIH project number | 5K24AI174971-02 |
| Project ID | NIH-10897028 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research are individuals living with HIV, particularly those who exhibit exceptional control of the virus.
✕Less likely to help
Patients who are not living with HIV or those who are not engaged in HIV treatment may not receive any benefit from this research.
What this research studies
This research focuses on mentoring young scientists to enhance their skills in HIV-related clinical research. It aims to develop innovative methods to understand how HIV persists in the body and how the immune system can control the virus. By fostering collaboration among these junior investigators, the project seeks to generate new insights into HIV pathogenesis and potential cures. Patients may benefit from advancements in treatment strategies that emerge from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for managing and potentially curing HIV.
How similar studies have gone: Previous research has shown promise in developing innovative approaches to HIV treatment, indicating that this area of study has potential for significant breakthroughs.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Henrich, Timothy Jensen — University of California, San Francisco
- Study coordinator: Henrich, Timothy Jensen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.